Sign In
Buy ILMN
$205.10
+0.0100 (+0.0049%)
At Close: Jul 31, 2026
Illumina, Inc. (ILMN) Q4 2025 Earnings Call Transcript
08:14pm, Thursday, 05'th Feb 2026
Illumina, Inc. (ILMN) Q4 2025 Earnings Call Transcript
Illumina (ILMN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
08:00pm, Thursday, 05'th Feb 2026
While the top- and bottom-line numbers for Illumina (ILMN) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compa
Illumina (ILMN) Tops Q4 Earnings and Revenue Estimates
07:02pm, Thursday, 05'th Feb 2026
Illumina (ILMN) came out with quarterly earnings of $1.35 per share, beating the Zacks Consensus Estimate of $1.26 per share. This compares to earnings of $0.86 per share a year ago.
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2025
04:06pm, Thursday, 05'th Feb 2026
Fourth quarter 2025 results: Revenue of $1.16 billion, up 5% from Q4 2024 (up 4% on a constant currency basis) Ex-China revenue of $1.10 billion, up 8% from Q4 2024 (up 7% on a constant currency basis
Atlantic Union Bankshares Corp Boosts Holdings in Illumina, Inc. $ILMN
04:34am, Thursday, 05'th Feb 2026
Atlantic Union Bankshares Corp raised its position in Illumina, Inc. (NASDAQ: ILMN) by 5,779.8% during the undefined quarter, according to its most recent filing with the SEC. The firm owned 6,997 sha
Insights Into Illumina (ILMN) Q4: Wall Street Projections for Key Metrics
10:15am, Wednesday, 04'th Feb 2026
Beyond analysts' top-and-bottom-line estimates for Illumina (ILMN), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:55am, Tuesday, 03'rd Feb 2026
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Illumina will sequence up to 4,000 unique individual animals across 1,300 species, unlock genomic insights from 50-year-old biological samples Sequencing connects decades of preserved biodiversity wit
WCM Investment Management LLC Has $384.17 Million Position in Illumina, Inc. $ILMN
04:46am, Tuesday, 03'rd Feb 2026
WCM Investment Management LLC lowered its holdings in Illumina, Inc. (NASDAQ: ILMN) by 5.5% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commissi
ILMN Q4 Earnings Preview: NovaSeq X Momentum Likely to Aid Performance
10:41am, Monday, 02'nd Feb 2026
Illumina eyes Q4 growth on NovaSeq X momentum, new multiomic launches and stronger sequencing demand despite China export limits.
Illumina completes acquisition of SomaLogic
09:05am, Friday, 30'th Jan 2026
Deeply expands leadership in proteomics and multiomics Combined capabilities bring high scalability, flexibility, and affordability into protein analysis Combination leverages SomaScan with Illumin
Illumina (ILMN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:06am, Thursday, 29'th Jan 2026
Illumina (ILMN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:55am, Tuesday, 27'th Jan 2026
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
QRG Capital Management Inc. Decreases Holdings in Illumina, Inc. $ILMN
05:06am, Saturday, 24'th Jan 2026
QRG Capital Management Inc. reduced its position in Illumina, Inc. (NASDAQ: ILMN) by 52.5% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SE
Illumina, Inc. $ILMN Holdings Lifted by Chicago Partners Investment Group LLC
03:34am, Saturday, 24'th Jan 2026
Chicago Partners Investment Group LLC increased its holdings in Illumina, Inc. (NASDAQ: ILMN) by 90.5% in the undefined quarter, according to the company in its most recent 13F filing with the Securit
